camptothecin has been researched along with Leukemia, T-Cell in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (42.86) | 18.2507 |
| 2000's | 2 (28.57) | 29.6817 |
| 2010's | 2 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fan, ZC; Gao, ML; Han, KL; Liu, H; Sun, H; Teng, YO; Wang, J; Yu, P; Zhang, YM; Zhao, HY; Zhou, Y | 1 |
| Fritsch, G; Geyeregger, R; Printz, D; Stemberger, J; Witt, V | 1 |
| Lansdell, TA; Peddibhotla, S; Sharma, V; Tepe, JJ | 1 |
| Feng, YD; Gong, JP; Tan, HL; Tao, DD; Xiao, H; Xie, DX; Yu, CN | 1 |
| Taguchi, H | 1 |
| Fujimori, A; Harker, WG; Kapoor, R; Pommier, Y; Slade, DL | 1 |
| Masaoka, T; Ohashi, Y; Ohno, R; Okada, K; Ota, K; Shirakawa, S; Taguchi, T | 1 |
1 review(s) available for camptothecin and Leukemia, T-Cell
| Article | Year |
|---|---|
[Treatment of adult T-cell leukemia].
Topics: Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Transplantation; Camptothecin; Clinical Trials as Topic; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Granulocyte Colony-Stimulating Factor; Hematopoietic Stem Cell Transplantation; Humans; Irinotecan; Leukemia, T-Cell; Pentostatin; Piperazines; Prednisone; Vincristine | 1995 |
1 trial(s) available for camptothecin and Leukemia, T-Cell
| Article | Year |
|---|---|
[Late phase II clinical study of irinotecan hydrochloride (CPT-11) in the treatment of malignant lymphoma and acute leukemia. The CPT-11 Research Group for Hematological Malignancies].
Topics: Adolescent; Adult; Aged; Anorexia; Antineoplastic Agents, Phytogenic; Camptothecin; Diarrhea; Drug Administration Schedule; Female; Humans; Infusions, Intravenous; Irinotecan; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Lymphoma, Non-Hodgkin; Male; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1994 |
5 other study(ies) available for camptothecin and Leukemia, T-Cell
| Article | Year |
|---|---|
Synthesis and anti-cancer activity evaluation of 5-(2-carboxyethenyl)-isatin derivatives.
Topics: Antineoplastic Agents; Apoptosis; Cell Line, Tumor; Cell Proliferation; Drug Screening Assays, Antitumor; Humans; Isatin; Jurkat Cells; Leukemia, T-Cell; Membrane Potential, Mitochondrial; Mitochondria; Neoplasms | 2016 |
Novel single-platform multiparameter FCM analysis of apoptosis: Significant differences between wash and no-wash procedure.
Topics: Antibodies, Monoclonal; Antineoplastic Agents, Phytogenic; Apoptosis; Camptothecin; Cell Count; Cell Separation; Flow Cytometry; Humans; Jurkat Cells; Leukemia, T-Cell; Necrosis; Photopheresis; Reproducibility of Results; Solutions | 2010 |
Sensitization of tumor cells toward chemotherapy: enhancing the efficacy of camptothecin with imidazolines.
Topics: Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Camptothecin; Cell Death; Cell Line, Tumor; Drug Screening Assays, Antitumor; Humans; I-kappa B Proteins; Imidazolines; Leukemia, T-Cell; Luciferases; Models, Biological; Molecular Conformation; NF-kappa B; NF-KappaB Inhibitor alpha; Phosphorylation; Sensitivity and Specificity | 2004 |
[Effect of caffeine on camptothecin-induced apoptosis of Molt-4 cells].
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Caffeine; Camptothecin; Cell Line, Tumor; Cell Proliferation; Humans; Leukemia, T-Cell; S Phase | 2005 |
Altered topoisomerase I expression in two subclones of human CEM leukemia selected for resistance to camptothecin.
Topics: Acute Disease; Base Sequence; Camptothecin; Catalysis; DNA Damage; DNA Topoisomerases, Type I; DNA, Neoplasm; Drug Resistance; Humans; Leukemia, Experimental; Leukemia, T-Cell; Molecular Sequence Data; Neoplasm Proteins; RNA, Messenger; Topoisomerase I Inhibitors; Tumor Cells, Cultured | 1995 |